Uncommon membrane distribution of Shiga toxin glycosphingolipid receptors in toxin-sensitive human glomerular microvascular endothelial cells

Biological Chemistry

Volumn 393, Issue 3, 2012, Pages 133-147

  Betz, Josefine ^a   Bauwens, Andreas ^a   Kunsmann, Lisa ^a   Bielaszewska, Martina ^a   Mormann, Michael ^a   Humpf, Hans Ulrich ^a   Karch, Helge ^a   Friedrich, Alexander W ^a,b   Müthing, Johannes ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Gb3Cer; Gb4Cer; Glycolipids; Lipid rafts; Mass spectrometry; Microdomains

Indexed keywords

GLYCOSPHINGOLIPID; RECEPTOR; SHIGA TOXIN; SHIGA TOXIN RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CYTOTOXICITY; ELECTROSPRAY MASS SPECTROMETRY; GLOMERULAR MICROVASCULAR ENDOTHELIAL CELL; HUMAN; HUMAN CELL; MICROVASCULAR ENDOTHELIAL CELL; PRIORITY JOURNAL; THIN LAYER CHROMATOGRAPHY;

BRAIN; CELL LINE; CHOLESTEROL; CHROMATOGRAPHY, THIN LAYER; ENDOTHELIAL CELLS; GLOBOSIDES; GLYCOSPHINGOLIPIDS; HUMANS; KIDNEY GLOMERULUS; MEMBRANE MICRODOMAINS; MICROVESSELS; SHIGA TOXIN; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TRIHEXOSYLCERAMIDES;

EID: 84859840087     PISSN: 14316730     EISSN: 14374315     Source Type: Journal    
DOI: 10.1515/hsz-2011-0288     Document Type: Article

References (86)

1. Adams, J. and Ann, Q. (1993). Structure determination of sphingolipids by mass spectrometry. Mass Spectrom. Rev. 12, 51-85.
2. Ando, S., Kon, K., Isobe, M., and Yamakawa, T. (1973). Structural study on tetraglycosyl ceramide and gangliosides isolated from human red blood cells. J. Biochem. 73, 893-895.
3. Arfilli, V., Carnicelli, D., Rocchi, L., Ricci, F., Pagliaro, P., Tazzari, P.L., and Brigotti, M. (2010). Shiga toxin 1 and ricin A chain bind to human polymorphonuclear leucocytes through a common receptor. Biochem. J. 432, 173-180.
4. Bauwens, A., Bielaszewska, M., Kemper, B., Langehanenberg, P., von Bally, G., Reichelt, R., Mulac, D., Humpf, H.U., Friedrich, A.W., Kim, K.S., et al. (2011). Differential cytotoxic actions of Shiga toxin 1 and Shiga toxin 2 on microvascular and macro vascular endothelial cells. Thromb. Haemost. 105, 515-528.
5. Betz, J., Bielaszewska, M., Thies, A., Humpf, H.U., Dreisewerd, K., Karch, H., Kim, K.S., Friedrich, A.W., and Müthing, J. (2011). Shiga toxin glycosphingolipid receptors in microvascular and macrovascular endothelial cells: differential association with membrane lipid raft microdomains. J. Lipid Res. 52, 618-634.
6. Bevan, H.S., Slater, S.C., Clarke, H., Cahill, PA., Mathieson, P.W., Welsh, G.I., and Satchell, S.C. (2011). Acute laminar stress reversibly increases human glomerular endothelial cell permeability via the activation of endothelial nitric oxidase synthase. Am. J. Physiol. Renal Physiol. 304, F733-F742.
7. Bielaszewska, M. and Karch, H. (2005). Consequences of enterohaemorrhagic Escherichia coli infection for the vascular endothelium. Thromb. Haemost. 94, 312-318. (Pubitemid 41122485)
8. Bielaszewska, M., Mellmann, A., Zhang, W., Köck, R., Fruth, A., Bauwens, A., Peters, G., and Karch, H. (2011). Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study. Lancet Infect. Dis. 11, 671-676.
9. Boor, P., van Roeyen, C.R., Kunter, U., Villa, L., Bücher, E., Hohenstein, B., Hugo, C.P., Eriksson, U., Satchell, S.C., Mathieson, P.W., et al. (2010). PDGF-C mediates glomerular capillary repair. Am. J. Pathol. 177, 58-69.
10. Brigotti, M., Carnicelli, D., Ravanelli, E., Barbieri, S., Ricci, F., Bontadini, A., Tozzi, A.E., Scavia, G., Caprioli, A., and Tazzari, P.L. (2008). Interactions between Shiga toxins and human polymorphonuclear leukocytes. J. Leukoc. Biol. 84, 1019-1027.
11. Brigotti, M., Tazzari, P.L., Ravanelli, E., Carnicelli, D., Rocchi, L., Arfilli, V., Scavia, G., Minelli, F., Ricci, F., Pagliaro, P., et al. (2011). Clinical relevance of Shiga toxin concentrations in the blood of patients with haemolytic uremic syndrome. Pediatr. Infect. Dis. J. 30, 486-490.
12. Brown, D.A. and Rose, J.K. (1992). Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68, 533-544.
13. Chester, M.A. (1999). IUPAC-IUB Joint Commission on Biochemical Nomenclature (JCBN). Nomenclature of glycolipids. Recommendations 1997. Glycoconj. J. 16, 1-6. (Pubitemid 129748008)
14. Distler, U., Hülsewig, M., Souady, J., Dreisewerd, K., Haier, J., Senninger, N., Friedrich, A.W., Karch, H., Hillenkamp, F., Berkenkamp, S., et al. (2008). Matching IR-MALDI-o-TOF mass spectrometry with the TLC overlay binding assay and its clinical application for tracing tumor-associated glycosphingolipids in hepatocellular and pancreatic cancer. Anal. Chem. 80, 1835-1846. (Pubitemid 351458025)
15. Distler, U., Souady, J., Hülsewig, M., Drmić-Hofman, I., Haier, J., Friedrich, A.W., Karch, H., Senninger, N., Dreisewerd, K., Berkenkamp, S., et al. (2009). Shiga toxin receptor Gb3Cer/ CD77: tumor association and promising therapeutic target in pancreas and colon cancer. PLoS ONE 4, e6813.
16. Domon, B. and Costello, C.E. (1988a). A systematic nomenclature for carbohydrate fragmentations in FAB-MS/MS spectra of glycoconjugates. Glycoconj. J. 5, 397-40.
17. Domon, B. and Costello, C.E. (1988b). Structure elucidation of glycosphingolipids and gangliosides using high-performance tandem mass spectrometry. Biochemistry 27, 1534-1543. (Pubitemid 18077449)
18. Eggeling, C., Ringemann, C., Medda, R., Schwarzmann, G., Sandhoff, K., Polyakova, S., Belov, V.N., Hein, B., von Middendorff, C., Schönle, A., et al. (2009). Direct observation of the nanoscale dynamics of membrane lipids in a living cell. Nature 457, 1159-1162.
19. Falguières, T., Mallard, F., Baron, C., Hanau, D., Lingwood, C., Goud, B., Salamero, J., and Johannes, L. (2001). Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes. Mol. Biol. Cell 12, 2453-2468. (Pubitemid 33051968)
20. Farwanah, H., Kolter, T., and Sandhoff, K. (2011). Mass spectrometric analysis of neutral sphingolipids: methods, applications, and limitations. Biochim. Biophys. Acta 1811, 854-860.
21. Friedrich, A.W., Bielaszewska, M., Zhang, W.L., Pulz, M., Kuczius, T., Ammon, A., and Karch, H. (2002). Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185, 74-84. (Pubitemid 34043019)
22. Geelen, J.M., van der Velden, T.J., van den Heuvel, L.P., and Monnens, L.A. (2007). Interactions of Shiga-like toxin with human peripheral blood monocytes. Pediatr. Nephrol. 22, 1181-1187.
23. Goswami, S.K. and Frey, C.F. (1970). Manganous chloride spray reagent for cholesterol and bile acids on thin-layer chromatograms. J. Chromatogr. 53, 389-390.
24. Gupta, G. and Surolia, A. (2010). Glycosphingolipids in microdomain formation and their spatial organization. FEBS Lett. 584, 1634-1641.
25. Hoey, D.E., Sharp, L., Currie, C., Lingwood, C.A., Gally, D.L., and Smith, D.G. (2003). Verotoxin 1 binding to intestinal crypt epithelial cells results in localization to lysosomes and abrogation of toxicity. Cell Microbiol. 5, 85-97. (Pubitemid 36395123)
26. Hoffmann, P., Hülsewig, M., Duvar, S., Ziehr, H., Mormann, M., Peter-Katalinić, J., Friedrich, A.W., Karch, H., and Müthing, J. (2010). On the structural diversity of Shiga toxin glycosphingolipid receptors in lymphoid and myeloid cells determined by nanoelectrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 24, 2295-2304.
27. Hunt, J.M. (2010). Shiga toxin-producing Escherichia coli (STEC). Clin. Lab. Med. 30, 21-45.
28. Hurley, B.P., Thorpe, C.M., and Acheson, D.W. (2001). Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration. Infect. Immun. 69, 6148-6155. (Pubitemid 32885176)
29. Iwabuchi, K., Prinetti, A., Sonnino, S., Mauri, L., Kobayashi, T., Ishii, K., Kaga, N., Murayama, K., Kurihara, H., Nakayama, H., et al. (2008). Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediated superoxide generation and migration in neutrophils. Glycoconj. J. 25, 357-374.
30. Karch, H., Tarr, P.I., and Bielaszewska, M. (2005). Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295, 405-418. (Pubitemid 41225453)
31. Karch, H., Friedrich. A.W., Gerber, A., Zimmerhackl, L.B., Schmidt, M.A., and Bielaszewska, M. (2006). New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome. Semin. Thromb. Hemost. 32, 105-112.
32. Khan, F., Proulx, F., and Lingwood, C.A. (2009). Detergent-resistant globotriaosyl ceramide may define verotoxin/glomerulirestricted hemolytic uremic syndrome pathology. Kidney Int. 75, 1209-1216.
33. Kovbasnjuk, O., Edidin, M., and Donowitz, M. (2001). Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 114, 4025-4031. (Pubitemid 33115023)
34. Lencer, W.I. and Saslowsky, D. (2005). Raft trafficking of AB 5 subunit bacterial toxins. Biochim. Biophys. Acta 1746, 314-321. (Pubitemid 41815025)
35. Levery, S.B. (2005). Glycosphingolipid structural analysis and glycosphingolipidomics. Methods Enzymol. 405, 300-369. (Pubitemid 43081964)
36. Li, Y., Zhou, D., Xia, C., Wang, P.G., and Levery, S.B. (2008). Sensitive quantitation of isoglobotriaosylceramide in the presence of isobaric components using electrospray ionization-ion trap mass spectrometry. Glycobiology 18, 166-176. (Pubitemid 351168255)
37. Li, Y., Thapa, P., Hawke, D., Kondo, Y., Furukawa, K., Furukawa, K., Hsu, F.F., Adlercreutz, D., Weadge, J., Palcic, M.M., et al. (2009). Immunologic glycosphingolipidomics and NKT cell development in mouse thymus. J. Proteome Res. 8, 2740-2751.
38. Li, Y., Arigi, E. Eichert, H., and Levery, S.B. (2010). Mass spectrometry of fluorocarbon-labeled glycosphingolipids. J. Mass Spectrom. 45, 504-519.
39. Lingwood, C.A. (1996). Role of verotoxin receptors in pathogenesis. Trends Microbiol. 4, 147-153. (Pubitemid 26135305)
40. Lingwood, C.A., Binnington, B., Manis, A., and Branch, D.R. (2010). Globotriaosyl ceramide receptor function - where membrane structure and pathology intersect. FEBS Lett. 584, 1879-1886.
41. Lingwood, D. and Simons, K. (2007). Detergent resistance as a tool in membrane research. Nat. Protoc. 2, 2159-2165. (Pubitemid 351565854)
42. Lingwood, D. and Simons, K. (2010). Lipid rafts as a membraneorganizing principle. Science 327, 46-50.
43. Mahfoud, R., Manis, A., and Lingwood, C.A. (2009). Fatty aciddependent globotriaosyl ceramide receptor function in detergent resistant model membranes. J. Lipid Res. 50, 1744-1755.
44. Meisen, I., Friedrich, A.W., Karch, H., Witting, U., Peter- Katalinić, J., and Müthing, J. (2005). Application of combined highperformance thin-layer chromatography immunostaining and nanoelectrospray ionization quadrupole time-of-flight tandem mass spectrometry to the structural characterization of high- and low-affinity binding ligands of Shiga toxin 1. Rapid Commun. Mass Spectrom. 19, 3659-3665. (Pubitemid 41812671)
45. Meisen, I., Peter-Katalinić, J., and Müthing, J. (2003). Discrimination of neolacto-series gangliosides with α2-3- and α2-6-linked N-acetylneuraminic acid by nanoelectrospray ionization lowenergy collision-induced dissociation tandem quadrupole TOF MS. Anal. Chem. 75, 5719-5725. (Pubitemid 37356452)
46. Meisen, I., Peter-Katalinić, J., and Müthing, J. (2004). Direct analysis of silica gel extracts from immunostained glycosphingolipids by nanoelectrospray ionization quadrupole time-of-flight mass spectrometry. Anal. Chem. 76, 2248-2255. (Pubitemid 38496065)
47. Meisen, I., Mormann, M., and Müthing, J. (2011). Thin-layer chromatography, overlay technique and mass spectrometry: a versatile triad advancing glycosphingolipidomics. Biochim. Biophys. Acta 1811, 875-896.
48. Mellmann, A., Harmsen, D., Cummings, C.A., Zentz, E.B., Leopold, S.R., Rico, A., Prior, K., Szczepanowski, R., Ji, Y., Zhang, W., et al. (2011). Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS ONE 6, e22751.
49. Merrill, A.H. Jr, Stokes, T.H., Momin, A., Park, H., Portz, B.J., Kelly, S., Wang, E., Sullards, M.C., and Wang, M.D (2009). Sphingolipidomics: a valuable tool for understanding the roles of sphingolipids in biology and disease. J. Lipid Res. 50, S97-S102.
50. Misselwitz, J., Karch, H., Bielaszewska, M., John, U., Ringelmann, F., Rönnefarth, G., and Patzer, L. (2003). Cluster of hemolyticuremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr. Infect. Dis. J. 22, 349-354. (Pubitemid 36461038)
51. Müthing, J. (1998). TLC in structure and recognition studies of glycosphingolipids. In: Methods in Molecular Biology, E.F. Hounsell, ed. (Totawa, NJ: Humana Press), pp. 183-195.
52. Müthing, J. and Distler, U. (2010). Advances on the compositional analysis of glycosphingolipids combining thin-layer chromatography with mass spectrometry. Mass Spectrom. Rev. 29, 425-479.
53. Müthing, J., Duvar, S., Heitmann, D., Hanisch, F.G., Neumann, U., Lochnit, G., Geyer, R., and Peter-Katalinic, J. (1999). Isolation and structural characterization of glycosphingolipids of in vitro propagated human umbilical vein endothelial cells. Glycobiology 9, 459-468. (Pubitemid 29240343)
54. Müthing, J., Schweppe, C.H., Karch, H., and Friedrich, A.W. (2009). Shiga toxins, glycosphingolipid diversity, and endothelial cell injury. Thromb. Haemost. 101, 252-264.
55. Obrig, T.G. (2010). Escherichia coli Shiga toxin mechanisms of action in renal disease. Toxins 2, 2769-2794.
56. Okuda, T., Nakakita, S.I., and Nakayama, K.I. (2010). Structural characterization and dynamics of globotetraosylceramide in vascular endothelial cells under TNF-α stimulation. Glycoconj. J. 27, 287-296.
57. Olds, E.G. (1938). Distribution of sums of squares of rank differences for small number of individuals. Ann. Math. Stat. 9, 133-148.
58. Prinetti, A., Loberto, N., Chigorno, V., and Sonnino, S. (2009). Glycosphingolipids behaviour in complex membranes. Biochim. Biophys. Acta 1788, 184-193.
59. Psotka, M.A., Obata, F., Kolling, G.L., Gross, L.K., Saleem, M.A., Satchell, S.C., Mathieson, P.W., and Obrig, T.G. (2009). Shiga toxin targets the murine renal collecting duct epithelium. Infect. Immun. 77, 959-969.
60. Pust, S., Dyve, A.B., Torgersen, M.L., van Deurs, B., and Sandvig, K. (2010). Interplay between toxin transport and flotillin localization. PLoS ONE 5, e8844.
61. Raa, H., Grimmer, S., Schwudke, D., Bergan, J., Wälchli, S., Skotland, T., Shevchenko, A., and Sandvig, K. (2009). Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin. Traffic 10, 868-882.
62. Römer, W., Berland, L., Chambon, V., Gaus, K., Windschiegl, B., Tenza, D., Aly, M.R.E., Fraisier, V., Florent, J.-C., Perrais, D., et al. (2007). Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450, 670-675. (Pubitemid 350207679)
63. Roumenina, L.T., Jablonski, M., Hue, C., Blouin, J., Dimitrov, J.D., Dragon-Durey, M.A., Cayla, M., Fridman, W.H., Macher, M.A., Ribes, D., et al. (2009). Hyperfunctional C3 convertase leads to complement deposition on endothelial cells and contributes to atypical hemolytic uremic syndrome. Blood 114, 2837-2845.
64. Sandhoff, K. and Kolter, T. (2003). Biosynthesis and degradation of mammalian glycosphingolipids. Philos. Trans. R. Soc. Lond. B. 358, 847-861. (Pubitemid 36639708)
65. Sandvig, K. (2001). Shiga toxins. Toxicon 39, 1629-1635. (Pubitemid 32786996)
66. Sandvig, K., Bergan, J., Dyve, A.B., Skotland, T., and Torgersen, M.L. (2010a). Endocytosis and retrograde transport of Shiga toxin. Toxicon 56, 1181-1185.
67. Sandvig, K., Torgersen, M.L., Engedal, N., Skotland, T., and Iversen, T.G. (2010b). Protein toxins from plants and bacteria: probes for intracellular transport and tools in medicine. FEBS Lett. 584, 2626-2634.
68. Satchell, S.C., Tasman, C.H., Singh, A., Ni, L., Geelen, J., von Ruhland, C.J., O'Hare, M.J., Saleem, M.A., van den Heuvel, L.P., and Mathieson, P.W. (2006). Conditionally immortalized human glomerular endothelial cells expressing fenestrations in response to VEGF. Kidney Int. 69, 1633-1640.
69. Schweppe, C.H., Bielaszewska, M., Pohlentz, G., Friedrich, A.W., Büntemeyer, H., Schmidt, M.A., Kim, K.S., Peter-Katalinić, J., Karch, H., and Müthing, J. (2008). Glycosphingolipids in vascular endothelial cells: relationship of heterogeneity in Gb3Cer/ CD77 receptor expression with differential Shiga toxin 1 cytotoxicity. Glycoconj. J. 25, 291-304.
70. Schweppe, C.H., Hoffmann, P., Nofer, J.R., Pohlentz, G., Mormann, M., Karch, H., Friedrich, A.W., and Müthing, J. (2010). Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors. J. Lipid Res. 51, 2282-2294.
71. Shaner, R.L., Allegood, J.C., Park, H., Wang, E., Kelly, S., Haynes, C.A., Sullards, M.C., and Merrill, A.H. Jr. (2009). Quantitative analysis of sphingolipids for lipidomics using triple quadrupole and quadrupole linear ion trap mass spectrometers. J. Lipid Res. 50, 1692-1707.
72. Shogomori, H. and Brown, D.A. (2003). Use of detergents to study membrane rafts: the good, the bad, and the ugly. Biol. Chem. 384, 1259-1263. (Pubitemid 37168692)
73. Siegel, S. and Castellan, N.J. Jr. (1988). Nonparametric Statistics for the Behavioral Sciences, 2nd edition (New York: McGraw-Hill).
74. Singh, A., Satchell, S.C., Neal, C.R., McKenzie, E.A., Tooke, J.E., and Mathieson, P.W. (2007). Glomerular endothelial glycocalyx constitutes a barrier to protein permeability. J. Am. Soc. Nephrol. 18, 2885-2893. (Pubitemid 350058395)
75. Slater, S.C., Beachley, V., Hayes, T., Zhang, D., Welsh, G.I., Saleem, M.A., Mathieson, P.W., Wen, X., Su, B., and Satchell, S.C. (2011). An in vitro model of the glomerular capillary wall using electrospun collagen nanofibres in a bioartificial composite basement membrane. PLoS ONE 6, e20802.
76. Smith, D.C., Sillence, D.J., Falguières, T., Jarvis, R.M., Johannes, L., Lord, J.M., Platt, F.M., and Roberts, L.M. (2006). The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol. Biol. Cell. 17, 1375-1387. (Pubitemid 43376557)
77. Sonnino, S. and Prinetti, A. (2009). Sphingolipids and membrane environments for caveolin. FEBS Lett. 583, 597-606.
78. Sonnino, S., Prinetti, A., Nakayama, H., Yangida, M., Ogawa, H., and Iwabuchi, K. (2009). Role of very long fatty acid-containing glycosphingolipids in membrane organization and cell signaling: the model of lactosylceramide in neutrophils. Glycoconj. J. 26, 615-621.
79. Stins, M.F., Gilles, F., and Kim, K.S. (1997). Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76, 81-90. (Pubitemid 27272632)
80. Summers, S.A., van der Veen, B.S., O'Sullivan, K.M., Gan, P.Y., Ooi, J.D., Heeringa, P., Satchell, S.C., Mathieson, P.W., Saleem, M.A., Visvanathan, K., et al. (2010). Intrinsic renal cell and leukocyte-derived TLR4 aggravate experimental anti-MPO glomerulonephritis. Kidney Int. 78, 1263-1274.
81. Tam, P., Mahfoud, R., Nutikka, A., Khine, A.A., Binnington, B., Paroutis, P., and Lingwood, C. (2008). Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide- containing lipid assemblies. J. Cell Physiol. 216, 750-763.
82. Tarr, P.I., Gordon, C.A., Chandler, W.L. (2005). Shiga-toxinproducing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073-1086. (Pubitemid 40386785)
83. Torgersen, M.L., Engedal, N., Pedersen, A.M., Husebye, H., Espevik, T., Sandvig, K. (2011). Toll-like receptor 4 facilitates binding of Shiga toxin to colon carcinoma and primary umbilical vein endothelial cells. FEMS Immunol. Med. Microbiol. 61, 63-75.
84. Vyas, K.A., Patel, H.V., Vyas, A.A., and Schnaar, R.L. (2001). Segregation of gangliosides GM1 and GD3 on cell membranes, isolated membrane rafts, and defined supported lipid monolayers. Biol. Chem. 382, 241-50. (Pubitemid 32243932)
85. Warnier, M., Römer, W., Geelen, J., Lesieur, J., Amessou, M., van den Heuvel, L., Monnens, L., and Johannes, L. (2006). Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells. Kidney Int. 70, 2085-2091.
86. Zoja, C., Buelli, S., and Morigi, M. (2010). Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction. Pediatr. Nephrol. 25, 2231-2240.